Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implication of the Antiapoptotic Protein BCL-B in the Pathogenesis of Multiple Myeloma

NCT01270009 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT01270009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01270009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implication of the Antiapoptotic Protein BCL-B in the Pathogenesis of Multiple Myeloma
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
November 30, 2013
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma